ライフサイエンスコーパス: unfractionated

1 ncidence of SMNs was in survivors exposed to unfractionated (600-1000 cGy) or high-dose fractionated

2 The unfractionated and fractionated samples were analyzed by

3 utralized the anticoagulant activity of both unfractionated and low molecular weight heparins and inh

4 is the primary receptor for the clearance of unfractionated and low molecular weight heparins in the

5 bes an emerging approach for the analysis of unfractionated and low molecular weight heparins, as wel

6 Although current anticoagulants such as unfractionated and low-molecular-weight heparins and the

7 IIIa receptor blockers), and anticoagulants (unfractionated and low-molecular-weight heparins).

8 subducted uranium was probably isotopically unfractionated before full oceanic oxidation, about 600

9 Limiting dilution analysis of unfractionated blood demonstrated a SRC frequency of 1 i

10 l surface phenotyping and transplantation of unfractionated blood, that approximately 1-5% of the tot

11 t device that isolates live tumor cells from unfractionated blood.

12 acrophages, their specific BM precursors, or unfractionated BM cells were delivered during liver inju

13 s in cord blood mononuclear cells and in the unfractionated BM of healthy and Fanconi anemia donors,

14 We demonstrate that macrophages within the unfractionated BMCs are responsible for the production o

15 l without injury; a single i.v. injection of unfractionated BMCs in healthy mice.

16 the co-infusion of limited numbers of donor unfractionated BMCs with human amnion-derived multipoten

17 Unfractionated BMDSC from diabetic Lepr mice were incuba

18 Unfractionated BMMNCs were isolated from adult mice via

19 ntation of CD34(+) cells (n = 8 patients) or unfractionated bone marrow (BM) or peripheral blood mono

20 Autologous, unfractionated bone marrow cells or skeletal myoblasts w

21 Despite the frequent clinical use of adult unfractionated bone marrow mononuclear cells (BMMNCs) fo

22 en expression profile as compared to plating unfractionated CD34(+)/lin(-)-enriched bone marrow monon

23 Although unfractionated CD4(+) T cells have not been shown to be

24 Transfer of unfractionated CD4(+) T cells induced severe colitis in

25 Injection of unfractionated, CD4 or CD8 allogeneic human peripheral b

26 c analysis of the proteotypic peptides in an unfractionated cell lysate.

27 Then, using unfractionated cell lysates, a homogeneous kinase assay

28 hed for long-term repopulating EpiSCs versus unfractionated cells (3.9- and 5.2-fold, respectively).

29 deed, B6/Rag(-/-) recipients of dnTGFbetaRII unfractionated cells develop features of liver disease s

30 the sera of rabbits or horses immunized with unfractionated cells isolated from pediatric human thymi

31 pproach to measuring protein levels in total unfractionated cellular proteins, and we apply this appr

32 orm of STAT3 than either ALDH(-)/CD133(-) or unfractionated colon cancer cells.

33 of these pools, along with the complete EMD unfractionated compound and positive and negative contro

34 r greater in magnitude than that launched by unfractionated conventional T, invariant natural killer

35 In addition, OKT3 treatment of unfractionated cord blood resulted in robust engraftment

36 Exosomes, although isolated from unfractionated culture media, were absent in highly infe

37 The transfer of unfractionated DBA/2J (DBA) splenocytes into B6D2F(1) (D

38 w abundant proteins compared to conventional unfractionated DIA analysis (1D-DIA).

39 ity (EC50 13 +/- 0.6 mug Cu/L) than were the unfractionated dissolved FAs (EC50 39 +/- 0.4 and 41 +/-

40 Using the breakthrough with unfractionated DOM as a baseline, on average, the water

41 regimen for the Ad5 vaccine did not increase unfractionated ELISpot responses compared with the Ad5 v

42 m liver replacement after transplantation of unfractionated embryonic day (ED) 14 fetal liver stem/pr

43 While unfractionated Epicor was inactive, the C18 resin-bindin

44 responses in the gut using intact tissues or unfractionated epithelial cells, thereby limiting conclu

45 (nanoparticle tracking analysis) analyses of unfractionated exosomes were also conducted to evaluate

46 dditive toxicity was measured when comparing unfractionated extracts to fractionated extracts in pre-

47 all of the sharp peaks that were present in unfractionated extracts, along with some broad signal.

48 Fractionated and unfractionated FAs obtained from streamwater and suspend

49 mpare the quality of SELDI-TOF MS data using unfractionated, fractionated plasma samples and abundant

50 The three-copy construct, GST-HB3, detected unfractionated free heparin (UFH) as low as 39ng/ml (equ

51 was observed between GTPP constituents, with unfractionated GTPP more potently preconditioning cells

52 ow-molecular-weight heparin (73%, n=487) and unfractionated heparin (15%, n=97).

53 ing enoxaparin compared with those receiving unfractionated heparin (2.3% versus 1.4%; P=0.022) but s

54 oembolism for no chemical prophylaxis (33%), unfractionated heparin (29%), dalteparin (40%), or infer

55 found in death at 30 days for enoxaparin vs unfractionated heparin (3.0% vs 3.0%; odds ratio [OR], 1

56 ary intervention were randomized to low-dose unfractionated heparin (50 U/kg) or standard-dose unfrac

57 , or 0.175 [671] mg/kg/h) or to a control of unfractionated heparin (60 IU/kg intravenous bolus follo

58 ous thromboembolism), enoxaparin (n=666) and unfractionated heparin (669) were given for 10.5 days (S

59 venous thromboembolism by 43% compared with unfractionated heparin (68 [10%] vs 121 [18%]; relative

60 leeding was higher with enoxaparin than with unfractionated heparin (7 [1%] vs 0; p=0.015).

61 ing was similar with enoxaparin (69 [8%]) or unfractionated heparin (71 [8%]; p=0.83).

62 ctionated heparin (50 U/kg) or standard-dose unfractionated heparin (85 U/kg or 60 U/kg with glycopro

63 n or sterile saline containing 5000 units of unfractionated heparin (control).

64 th 184 (9.4%) of 1952 patients randomized to unfractionated heparin (hazard ratio [HR], 0.88; 95% con

65 fated hirugen (IC(50) = 1.2 +/- 0.2 microm), unfractionated heparin (IC(50) = 56.6 +/- 8.4 microg/ml)

66 gned randomly to eptifibatide + reduced dose unfractionated heparin (n = 298), eptifibatide + reduced

67 esigned to capture the desired attributes of unfractionated heparin (UFH) and low-molecular-weight he

68 e most common pharmocoprevention strategies, unfractionated heparin (UFH) and the low-molecular-weigh

69 st effectiveness of enoxaparin compared with unfractionated heparin (UFH) as adjunctive therapy for f

70 ate whether enoxaparin (ENOX) is superior to unfractionated heparin (UFH) as adjunctive therapy for p

71 usted otamixaban regimens or weight-adjusted unfractionated heparin (UFH) before percutaneous coronar

72 safety and effectiveness of bivalirudin and unfractionated heparin (UFH) for carotid artery stenting

73 comparative outcomes between bivalirudin and unfractionated heparin (UFH) have not been well describe

74 icacy and safety of enoxaparin (ENOX) versus unfractionated heparin (UFH) in patients with ST-segment

75 all efficacy and safety of enoxaparin versus unfractionated heparin (UFH) in the SYNERGY (Superior Yi

76 Unfractionated heparin (UFH) is a widely used anticoagul

77 Monitoring unfractionated heparin (UFH) is crucial to prevent over-

78 Unfractionated heparin (UFH) is currently used during CP

79 Unfractionated heparin (UFH) is frequently administered

80 rction patients that received abciximab with unfractionated heparin (UFH) or bivalirudin during percu

81 randomized to bivalirudin (n = 1,800) versus unfractionated heparin (UFH) plus a glycoprotein IIb/III

82 we characterized the interaction of PF4 with unfractionated heparin (UFH), its 16-, 8-, and 6-mer sub

83 All patients received aspirin, unfractionated heparin (UFH), or enoxaparin and early ca

84 normalized ratio (INR) affects the dosing of unfractionated heparin (UFH).

85 occurring in up to 5% of patients exposed to unfractionated heparin (UFH).

86 harmacological and practical advantages over unfractionated heparin (UFH).

87 lecular weight heparin (LMWH) is superior to unfractionated heparin (UH) for venous thromboembolism (

88 noxaparin 40 mg subcutaneously once daily or unfractionated heparin 5000 U subcutaneously every 12 h

89 imilar between groups (enoxaparin 11 [1%] vs unfractionated heparin 6 [1%]; p=0.23).

90 ulfated, the inhibitors did not compete with unfractionated heparin alluding to a novel site of inter

91 ctivator over 15 hours (n=30; USAT group) or unfractionated heparin alone (n=29; heparin group).

92 b/IIIa inhibitors, and 676 patients received unfractionated heparin alone.

93 ) occurred in 12.2 percent of patients given unfractionated heparin and 10.1 percent of those given e

94 n occurred in 14.5 percent of patients given unfractionated heparin and 11.7 percent of those given e

95 red in 4.5 percent of the patients receiving unfractionated heparin and 3.0 percent of those receivin

96 A total of 6055 patients received study unfractionated heparin and a fibrin-specific lytic and h

97 /LV) ratio >/=1.0 were randomized to receive unfractionated heparin and an USAT regimen of 10 to 20 m

98 on on noncovalent complexes formed by intact unfractionated heparin and antithrombin-III, interaction

99 he pharmacologic methods, including low-dose unfractionated heparin and low molecular weight heparin.

100 with low-molecular-weight heparin (LMWH) or unfractionated heparin and mortality, pulmonary embolism

101 MWH) prepared by partial depolymerization of unfractionated heparin are used globally to treat coagul

102 n when treated with enoxaparin compared with unfractionated heparin as adjunctive therapy with fibrin

103 eight heparin (LMWH) is modestly superior to unfractionated heparin at preventing recurrent DVT and i

104 hylaxis with low-molecular-weight heparin or unfractionated heparin at standard doses.

105 ivative has less anticoagulant activity than unfractionated heparin but retains the inherent anti-inf

106 arin Conjugate (CHC), a compound of multiple unfractionated heparin chains, coats cells with a glycoc

107 A progressive increase in unfractionated heparin concentration results in a linear

108 ncreased from 77% to 84%, whereas the use of unfractionated heparin decreased from 22% to 8.4% (p < 0

109 w-molecular-weight heparin compared with bid unfractionated heparin decreases pulmonary embolism and

110 isk, P<0.001); 7.5 percent of patients given unfractionated heparin died, as did 6.9 percent of those

111 clotting time (ACT) is widely used to guide unfractionated heparin dosing during percutaneous corona

112 In the Fondaparinux With Unfractionated Heparin During Revascularization in Acute

113 of TAVI has been empirically determined, and unfractionated heparin during the procedure followed by

114 go transfemoral TAVR with bivalirudin versus unfractionated heparin during the procedure.

115 e antithrombotic therapy with bivalirudin or unfractionated heparin during this procedure.

116 ospitalization is superior to treatment with unfractionated heparin for 48 hours but is associated wi

117 ute VTE treated with low-molecular-weight or unfractionated heparin for 5 to 11 days, we compared dab

118 Patients were given unfractionated heparin for anticoagulation, as they woul

119 ut the index hospitalization or weight-based unfractionated heparin for at least 48 hours.

120 nitial therapy with open-label enoxaparin or unfractionated heparin for at least 5 days.

121 ficacy and safety of enoxaparin with that of unfractionated heparin for patients with stroke.

122 no differences in the association of LMWH vs unfractionated heparin for preventing mortality, pulmona

123 ter, followed by a VKA (LMWH and VKA); or 4) unfractionated heparin for the first trimester, followed

124 Subcutaneous LMWH has replaced unfractionated heparin for the initial treatment of VTE.

125 preferred drug-based approach over standard unfractionated heparin for the prevention of venous thro

126 w-molecular-weight heparin, enoxaparin, with unfractionated heparin for this purpose.

127 rin, enoxaparin is a suitable alternative to unfractionated heparin for treatment of non-ST-elevation

128 ecurrent DVT and is at least as effective as unfractionated heparin for treatment of pulmonary emboli

129 schaemic stroke, enoxaparin is preferable to unfractionated heparin for venous thromboembolism prophy

130 The hypothesis that unfractionated heparin functions to decrease inflammator

131 occurred in 12.0 percent of patients in the unfractionated heparin group and 9.9 percent of those in

132 ic end points in the REG1 group and 1 in the unfractionated heparin group, with 1 major bleed in the

133 ted heparin group, with 1 major bleed in the unfractionated heparin group.

134 ecent trials comparing use of enoxaparin and unfractionated heparin in ACS have yielded less robust e

135 d controlled trials comparing enoxaparin and unfractionated heparin in non-ST-segment elevation ACS w

136 ticoagulation with bivalirudin compared with unfractionated heparin in patients undergoing peripheral

137 3 randomized trial compared bivalirudin with unfractionated heparin in patients undergoing transfemor

138 um of ACS, enoxaparin is more effective than unfractionated heparin in preventing the combined end po

139 ular-weight heparin is more efficacious than unfractionated heparin in preventing VTE (0.25% vs 0.68%

140 e improved the efficacy and safety of dosing unfractionated heparin in ST-segment elevation myocardia

141 se findings should be considered when dosing unfractionated heparin in support of fibrinolytic therap

142 MI at 30 days was observed for enoxaparin vs unfractionated heparin in the overall trial populations

143 omen was reduced by enoxaparin compared with unfractionated heparin in women (15.4% versus 18.3%; P=0

144 ents are receiving preoperatively apart from unfractionated heparin include low-molecular-weight hepa

145 Fondaparinux as compared with usual care (unfractionated heparin infusion or placebo) significantl

146 Unfractionated heparin is isolated from animal organs, p

147 ylaxis using low-molecular-weight heparin or unfractionated heparin is more likely in ICU patients wi

148 Unfractionated heparin is often used as adjunctive thera

149 hylaxis with low molecular weight heparin or unfractionated heparin is recommended in acute ischaemic

150 The use of bivalirudin versus unfractionated heparin monotherapy in patients without S

151 ous coronary intervention when compared with unfractionated heparin monotherapy was associated with l

152 [0.7% to -0.7%]; P=1.00) when compared with unfractionated heparin monotherapy.

153 Despite the use of a standard weight-based unfractionated heparin nomogram in ST-segment elevation

154 Our study reveals that unfractionated heparin not only prolongs the onset of cl

155 rcutaneous coronary intervention with either unfractionated heparin or bivalirudin monotherapy.

156 All patients received unfractionated heparin or enoxaparin before PCI and a 12

157 mes to one of three antithrombotic regimens: unfractionated heparin or enoxaparin plus a glycoprotein

158 Substitution of unfractionated heparin or enoxaparin with bivalirudin re

159 to receive bivalirudin (n=1928) or heparin (unfractionated heparin or enoxaparin; n=1870) plus a GPI

160 EACS) treated with eptifibatide/reduced-dose unfractionated heparin or eptifibatide/reduced-dose enox

161 Low-dose unfractionated heparin or low molecular weight heparin i

162 Periprocedural bridging with unfractionated heparin or low-molecular-weight heparin a

163 ologically mediated adverse drug reaction to unfractionated heparin or, less commonly, to low-molecul

164 ere randomized to bivalirudin (n = 1,800) or unfractionated heparin plus a glycoprotein IIb/IIIa inhi

165 Compared with unfractionated heparin plus a glycoprotein IIb/IIIa inhi

166 ty in those taking bivalirudin compared with unfractionated heparin plus a glycoprotein IIb/IIIa inhi

167 (310 of 5466 patients) randomized to receive unfractionated heparin plus eptifibatide (adjusted relat

168 duce the rate of ischemic events relative to unfractionated heparin plus eptifibatide but did increas

169 events and have a safety profile similar to unfractionated heparin plus eptifibatide.

170 in mortality with bivalirudin compared with unfractionated heparin plus glycoprotein IIb/IIIa inhibi

171 ortality and cardiac mortality compared with unfractionated heparin plus glycoprotein IIb/IIIa inhibi

172 ban (bolus and infusion, at 1 of 2 doses) or unfractionated heparin plus, at the time of percutaneous

173 Anticoagulation with unfractionated heparin remains the most common therapy u

174 Unfractionated heparin requirements to maintain a therap

175 Unfractionated heparin was administered in 33 (87%) and

176 myocardial uptake suppression protocol with unfractionated heparin was performed in all patients.

177 24 h before the examination, and 50 IU/kg of unfractionated heparin were administered intravenously 1

178 possibility to study interactions of intact unfractionated heparin with a client protein carried out

179 ctive as the current standard combination of unfractionated heparin with glycoprotein IIb/IIIa inhibi

180 -molecular-weight heparin (LMWH) or low dose unfractionated heparin with graded stockings has been va

181 were observed in the 14 trials that compared unfractionated heparin with low-molecular-weight heparin

182 both clotting and exogenous heparan sulfate (unfractionated heparin) released substantial amounts of

183 w-molecular-weight heparin (in comparison to unfractionated heparin) thromboprophylaxis lowered pulmo

184 1% of patients (23 for enoxaparin and 17 for unfractionated heparin).

185 ., aspirin, low-molecular-weight heparin, or unfractionated heparin).

186 These comprise studies with LMWH, unfractionated heparin, and vitamin K antagonists, with

187 The OSCS found in contaminated lots of unfractionated heparin, as well as a synthetically gener

188 ing a hirudin peptide (exosite 1 ligand) and unfractionated heparin, heparin octasaccharide, and gamm

189 ute ischaemic stroke that compared heparins (unfractionated heparin, heparinoids, or low-molecular-we

190 Compared with unfractionated heparin, low-molecular-weight heparin red

191 Parenteral unfractionated heparin, low-molecular-weight heparin, an

192 icoagulation therapy (initial treatment with unfractionated heparin, low-molecular-weight heparin, or

193 sion stockings, pneumatic compression boots, unfractionated heparin, low-molecular-weight heparin, or

194 Unfractionated heparin, non-anticoagulant heparin, hepar

195 tic dosages of low-molecular weight heparin, unfractionated heparin, or fondaparinux at admission.

196 nt of VTE with low-molecular-weight heparin, unfractionated heparin, or fondaparinux in hospitalized

197 favorable in-hospital outcomes compared with unfractionated heparin, the current standard of care.

198 infarction were randomized to enoxaparin or unfractionated heparin, the latter dosed according to th

199 In contrast to unfractionated heparin, this synthetic pentasaccharide t

200 dard of care (low-molecular-weight heparins, unfractionated heparin, vitamin K antagonists or fondapa

201 not been compared with warfarin, aspirin, or unfractionated heparin.

202 eeding, and despite the use of preprocedural unfractionated heparin.

203 ndard management for pulmonary embolism with unfractionated heparin.

204 llowed by 2 groups randomized 5:1 to REG1 or unfractionated heparin.

205 cost-saving or cost-effective compared with unfractionated heparin.

206 s with planned fibrinolysis to enoxaparin or unfractionated heparin.

207 who were treated with either bivalirudin or unfractionated heparin.

208 anticipated to receive either bivalirudin or unfractionated heparin.

209 affinity with TGFbeta1 compared to low MW or unfractionated heparin.

210 gnificantly lower with bivalirudin than with unfractionated heparin.

211 uction in ischemic events with standard-dose unfractionated heparin.

212 that Robo1 binds more tightly to full-length unfractionated heparin.

213 d to determine the constituents of GAGs from unfractionated heparin/HS from various bovine and porcin

214 g were low (3.0% for enoxaparin and 2.2% for unfractionated heparin; P =.13).

215 Either (unfractionated) heparin or low molecular weight heparin

216 S) of active pharmaceutical ingredient (API) unfractionated heparins (UFHs) from six different manufa

217 In vitro, low-molecular weight and unfractionated heparins stimulated sFlt-1 release from p

218 s derived from Asp-N and Glu-C digestions of unfractionated histones from calf thymus and acid-extrac

219 The primary end point was the unfractionated HIV-1 gag-specific interferon gamma enzym

220 development of infections permits lifesaving unfractionated HLA-identical or T cell-depleted haploide

221 novel approach to the analysis of glycans in unfractionated human biospecimens has been developed tha

222 dendritic cell coculture system, which uses unfractionated human PBMCs as the starting material.

223 In a previous study using unfractionated human peripheral blood mononuclear cells,

224 lly all of the misTTR hydrolytic activity of unfractionated human serum.

225 he survival of murine IEL subpopulations and unfractionated IEL derived from human intestines, an eff

226 Unfractionated iMPC-Heps did not form tumours, most prob

227 uantitative comparison with the proteomes of unfractionated leaves, thylakoids, and stroma.

228 ls possess regulatory activity, whereas both unfractionated LP lymphocytes and purified LP CD4(+) T c

229 bust, Dectin-1-dependent IL-22 production by unfractionated lung digest cells.

230 In unfractionated lymphocytes, this effect was seen in all

231 liver, and blood, but was rarely detected in unfractionated lymphoid tissues.

232 We demonstrate that targeted analysis of unfractionated lysates (2 hr) accurately reproduces the

233 Two years later, brother B received unfractionated marrow from brother A after reduced-inten

234 also inhibited the farnesylation of HDJ-2 in unfractionated mononuclear cells and purified myeloma ce

235 mature myotubes, as observed previously with unfractionated MPCs containing both SP and MP cells.

236 Conversely, unfractionated MSCs and CD146(-) cells induce differenti

237 D146(+) perivascular cells, as compared with unfractionated MSCs and CD146(-) cells, to sustain human

238 For a low concentration of unfractionated NOM (10 ppm), both fractions contributed

239 contribute to the stabilizing effect of the unfractionated NOM even in small proportions.

240 In many cases, unfractionated NOM provided better stability than its se

241 weight-average molecular weight, Mw, for the unfractionated NOM was 23,300 g/mol, determined by size

242 In the unfractionated NOM, the relative importance of the two c

243 By contrast, an unfractionated nuclear extract-based system in which Med

244 With the unfractionated OprF, we saw only rare channel formation.

245 .S. patients were randomized to: 1) heparin (unfractionated or enoxaparin) + GPI; 2) bivalirudin + GP

246 syndromes (ACS) were randomized to heparin (unfractionated or enoxaparin) plus glycoprotein IIb/IIIa

247 tively randomly assigned to receive heparin (unfractionated or enoxaparin) plus glycoprotein IIb/IIIa

248 nd high-risk ACS were randomized to heparin (unfractionated or enoxaparin) plus glycoprotein IIb/IIIa

249 Treatment with heparin (unfractionated or low molecular weight) prevented comple

250 ion to pharmacologic thromboprophylaxis with unfractionated or low-molecular-weight heparin (pneumati

251 ect of bivalirudin monotherapy compared with unfractionated or low-molecular-weight heparin plus opti

252 ) in ambulance to bivalirudin monotherapy vs unfractionated or low-molecular-weight heparin plus opti

253 primary PCI to receive either bivalirudin or unfractionated or low-molecular-weight heparin with opti

254 tic therapy, including aspirin, clopidogrel, unfractionated or low-molecular-weight heparin, and glyc

255 erated coagulation in the presence of either unfractionated or low-molecular-weight heparins more pot

256 Surprisingly, we found that incubation of unfractionated PBMC with IL-15 for 48 h resulted in the

257 ESI-MS/MS analyses, each using 250 ng of the unfractionated peptide mixture, at 95% confidence (FDR <

258 As observed by other investigators using unfractionated peripheral blood cells from patients with

259 s as well as CD4(-)CD8(-) cell fractions and unfractionated peripheral blood mononuclear cell samples

260 K cells (P = .02), overall K562 cytolysis by unfractionated peripheral blood mononuclear cells was no

261 eration sequencing of HIV-1 DNA derived from unfractionated peripheral blood mononuclear cells, ex vi

262 in activated CD4(+) T cells, monocytes, and unfractionated peripheral blood mononuclear cells.

263 Full-donor chimerism (FDC) in unfractionated peripheral blood was 42%; no patient achi

264 The peaks detected using the unfractionated plasma samples have the highest reproduci

265 roteins, present in complex materials (e.g., unfractionated plasma); (ii) select ligands to multiple

266 tive to low mug/ml protein concentrations in unfractionated plasma.

267 To identify the DC-SIGN ligand from unfractionated PNAg, we expressed the extracellular port

268 s less than that of the unbound fraction and unfractionated product, respectively.

269 Unfractionated properdin contains aggregates or high-ord

270 Recently, commercially available unfractionated properdin was shown to bind to certain bi

271 observations, preincubation of bacteria with unfractionated properdin, followed by the addition of pr

272 gonorrhoeae specifically using native versus unfractionated properdin.

273 Quantitative comparisons with proteomes of unfractionated proplastids and chloroplasts facilitated

274 milies directly at picogram levels of whole, unfractionated proteome.

275 the purified 170-kDa ZmpB/ZmpC fraction and unfractionated S. pneumoniae culture supernatant generat

276 also directly observed in the ESI MS of the unfractionated sample of the heat-stressed AT.

277 2/3, and 19 glycoforms of IgG4) directly in unfractionated samples of human plasma and we detect tra

278 Unfractionated samples were randomized into sets for tra

279 new and known peptides in both enriched and unfractionated samples.

280 nerate high-throughput proteomic profiles of unfractionated serum samples using an immobilized metal

281 increase in genotoxicity was measured in the unfractionated soil extract, as well as in four polar so

282 only one-third of all SL-ICs present in the unfractionated specimen.

283 tive transfer studies, transferring Ly5.1(+) unfractionated spleen cell CD4(+) or CD8(+) T cells from

284 The treatment of unfractionated splenic cells with ConA plus CT induced B

285 The treatment of unfractionated splenic cells with CT, LT-IIa, or LT-IIb

286 e developed a simplified technique that used unfractionated splenocytes as a precursor population and

287 Unfractionated splenocytes from donor mice without prote

288 In vitro proliferation of unfractionated splenocytes from tumor-bearing mice, as a

289 found that Treg expansion occurred only with unfractionated splenocytes, suggesting that accessory ce

290 lls with either purified Treg cells, or with unfractionated splenocytes.

291 Rag2(-/-) mice reconstituted with unfractionated STAT1(-/-) splenocytes (B cells and T cel

292 Separations are made of both unfractionated SWNTs and SWNT fractions made by use of s

293 ulations, the majority of ACT trials utilize unfractionated T cell subsets.

294 erefore represent a potential alternative to unfractionated T cells for promotion of allogeneic engra

295 PIT effectively suppressed AAI driven by unfractionated Th2 cells.

296 nd IL-13 mRNA and protein when compared with unfractionated (total) CD4+ Th2 cells.

297 Binding of unfractionated tRNA establishes that these molecules are

298 enriched 16.8-fold in tumorigenic cells over unfractionated (UNF) cells, such that 1 in 21,000 cells

299 Furthermore, transfusion of unfractionated wild-type blood into unconditioned, nonir

300 NanoLC-FAIMS-MS/MS of an unfractionated yeast tryptic digest using the modified F